This Article Full Text Full Text (PDF) All Versions of this Article: 22/10/1726    most recent 01.ATV.0000032134.92180.41v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pont, F. Articles by Vergès, B. Search for Related Content PubMed PubMed Citation Articles by Pont, F. Articles by Vergès, B. Related Collections Lipids Obesity Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1726.)
© 2002 American Heart Association, Inc.

Lipoproteins

Early Kinetic Abnormalities of ApoB-Containing Lipoproteins in Insulin-Resistant Women With Abdominal Obesity

Frédéric Pont; Laurence Duvillard; Emmanuel Florentin; Philippe Gambert; Bruno Vergès

From the Laboratoire de Biochimie des Lipoprotéines (F.P., L.D., E.F., P.G., B.V.), INSERM U 498, Faculté de Médecine, and Service Endocrinologie (B.V.), Diabétologie et Maladies Métaboliques, Centre Hospitalier Universitaire de Dijon, Dijon, France.

Correspondence to Pr Bruno Vergès, Service Endocrinologie, Hôpital du Bocage, BP 1542, 21034 Dijon, France. E-mail bruno.verges{at}chu-dijon.fr

Abstract

Objective— The kinetic abnormalities of apolipoprotein B (apoB)-containing lipoproteins in abdominally obese insulin-resistant individuals remain poorly understood. To determine the influence of insulin resistance, linked with abdominal obesity, on apoB metabolism at an early stage, we performed a stable isotope kinetic study of apoB in very low density lipoproteins (VLDLs), intermediate density lipoproteins (IDLs), and low density lipoproteins (LDLs) in 5 abdominally obese insulin-resistant women with normal fasting triglyceride levels and without impaired glucose tolerance and in 5 age-matched control women.

Methods and Results— Each subject received an intravenous injection of a 0.7 mg/kg bolus of L-[1-¹³C]leucine, immediately followed by a 16-hour constant infusion at 0.7 mg/kg per hour. Compared with control women, insulin-resistant women with abdominal obesity showed a significant 84% increase of the VLDL apoB production rate (27.18±11.53 versus 14.80±1.94 [control] mg/kg per day, P=0.009), a significant 54% increase of the IDL apoB production rate (20.63±3.66 versus 13.39±3.99 [control] mg/kg per day, P=0.009), and a significant 63% increase of the LDL apoB production rate (18.49±1.70 versus 11.33±3.79 [control] mg/kg per day, P=0.009), leading to significantly higher VLDL, IDL, and LDL apoB concentrations. The fractional catabolic rates of VLDL, IDL, and LDL apoB were not significantly different between abdominally obese insulin-resistant women and control women.

Conclusions— Our study shows that patients at an early stage of insulin resistance linked with abdominal obesity (without glucose intolerance or fasting hypertriglyceridemia) already have an altered metabolism of the VLDL-IDL-LDL cascade (increased VLDL, IDL, and LDL apoB production rates), which is consistent with the augmented risk of atherosclerosis observed in this population.

Key Words: insulin resistance • abdominal obesity • insulin • apolipoprotein B • lipids

This article has been cited by other articles:

				M. Adiels, S.-O. Olofsson, M.-R. Taskinen, and J. Boren Overproduction of Very Low-Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1225 - 1236. [Abstract] [Full Text] [PDF]

				B. Verges, J. M. Petit, L. Duvillard, G. Dautin, E. Florentin, F. Galland, and P. Gambert Adiponectin Is an Important Determinant of ApoA-I Catabolism Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1364 - 1369. [Abstract] [Full Text] [PDF]

				J. S. Cohn, B. W. Patterson, K. D. Uffelman, J. Davignon, and G. Steiner Rate of Production of Plasma and Very-Low-Density Lipoprotein (VLDL) Apolipoprotein C-III Is Strongly Related to the Concentration and Level of Production of VLDL Triglyceride in Male Subjects with Different Body Weights and Levels of Insulin Sensitivity J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3949 - 3955. [Abstract] [Full Text] [PDF]

				D. V. Chirieac, H. L. Collins, J. Cianci, J. D. Sparks, and C. E. Sparks Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E42 - E49. [Abstract] [Full Text] [PDF]

				J. M. Petit, M. Duong, E. Florentin, L. Duvillard, P. Chavanet, J. M. Brun, H. Portier, P. Gambert, and B. Verges Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic study J. Lipid Res., September 1, 2003; 44(9): 1692 - 1697. [Abstract] [Full Text] [PDF]